Document Detail


Prediction of focal extracapsular extension at radical prostatectomy: Relative merit of transrectal ultrasound, endorectal magnetic resonance imaging, prostate specific antigen, prostate specific antigen density, and systematic biopsy.
MedLine Citation:
PMID:  21224166     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
We conducted a study to compare the relative merits of prostate specific antigen (PSA), PSA density (PSAD), transrectal ultrasound (TRUS), endorectal magnetic resonance imaging (MRI), and systematic biopsy in the prediction of focal extracapsular extension (ECE) at radical prostatectomy. A retrospective review of patients who underwent TRUS, endorectal MRI, and radical prostatectomy at our institution was performed. Patients with a diagnosis of prostate cancer who were thought to be surgical candidates by digital rectal examination and TRUS underwent endorectal MRI prior to radical prostatectomy. Imaging, PSA, PSAD, and systematic biopsy results (tumor grade and fraction of positive systematic biopsies) were correlated with step-sectioned, radical prostatectomy pathologic data. Data was analyzed for the entire prostate and on each individual side. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and likelihood ratios were calculated for each modality, and receiver operating characteristic (ROC) curves were generated. Stepwise logistic regression analysis was used to weigh the relative contributions of preoperative parameters in predicting ECE. Data was collected from 54 patients who had sextant systematic biopsy, imaging, and radical prostatectomy. A total of 24 sides demonstrated ECE (19 patients, 5 with bilateral ECE). When assessed for the dominant prostate side and on a side-for-side basis, MRI had the highest sensitivity and NPV for detecting focal ECE. MRI also had the highest PPV, and TRUS had the highest specificity for side-for-side analysis. For the dominant prostate side, PSA had the highest specificity and PPV for detecting focal ECE. Of note, significant overlap was demonstrated in the 95% confidence intervals of all modalities with each other for all analyses. ROC analyses found MRI and Gleason sum to be superior for the dominant prostate side assessment and MRI and the fraction of positive systematic biopsies to be superior for a side-for-side analysis. Optimal likelihood ratios for positive test results were seen for PSA (dominant prostate side) and MRI (side-for-side), and for negative test results for MRI. Logistic regression demonstrated MRI and Gleason sum to be powerful predictors of ECE. Thus, we would conclude that endorectal MRI and tumor grade provide unique information in the prediction of focal ECE in select patients.
Authors:
J C Presti; H Hricak; K Shinohara; P R Carroll
Related Documents :
8816516 - Spiral ct angiography for suspected pulmonary embolism: a cost-effectiveness analysis.
19433016 - Diagnosis and neurosurgical treatment of intracranial vascular occlusive syndromes.
19561516 - Three-dimensional imaging of pulmonary veins by a novel steady-state free-precession ma...
11483196 - The usefulness of 3d mr angiography in surgery for ruptured cerebral aneurysms.
19021846 - Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas fr...
14749916 - Localized pigmented villonodular synovitis in the anteromedial compartment of the knee ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Urologic oncology     Volume:  2     ISSN:  1078-1439     ISO Abbreviation:  Urol. Oncol.     Publication Date:    1996 Nov-Dec
Date Detail:
Created Date:  2011-01-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9805460     Medline TA:  Urol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  177-83     Citation Subset:  -    
Affiliation:
Department of Urology, University of California School of Medicine, San Francisco, California, USA; Department of Urology, UCSF/Mt. Zion Cancer Center, San Francisco, California, USA; Department of Radiology, University of California School of Medicine, San Francisco, California, USA; Department of Radiology, UCSF/Mt. Zion Cancer Center, San Francisco, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transitional cell carcinoma of the renal pelvis and ureter: Outcome and patterns of relapse in patie...
Next Document:  Adjuvant radiation therapy for low stage testicular seminoma: Diagnosis and therapy in evolution.